Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.

Brucellosis is probably the commonest anthropozoonotic infection worldwide [1-3], but remains in various aspects an enigma in the 21st century [4]. Brucella melitensis remains the major cause of human disease worldwide, followed by B. abortus and B. suis, while rare but persisting cases of B. canis...

ver descrição completa

Detalhes bibliográficos
Autores: Ariza Cardenal, Javier, Bosilkowski, Mile, Cascio, Antonio, Colmenero, Juan D., Corbel, Michael J., Falagas, Matthew E., Memish, Ziad A., Roushan, Mohammad Reza Hansanjani, Rubinstein, Ethan, Sipsas, Nikolaos V., Solera, Javier, Young, Edward J., Pappas, Georgios
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2007
País:España
Recursos:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/43769
Acesso em linha:https://hdl.handle.net/2445/43769
Access Level:acceso abierto
Palavra-chave:Brucel·losi
Malalties infeccioses
Terapèutica
Brucellosis
Communicable diseases
Therapeutics
id ES_db8b5cd9ea1077344cd89bf8f3eac95a
oai_identifier_str oai:recercat.cat:2445/43769
network_acronym_str ES
network_name_str España
repository_id_str
spelling Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.Ariza Cardenal, JavierBosilkowski, MileCascio, AntonioColmenero, Juan D.Corbel, Michael J.Falagas, Matthew E.Memish, Ziad A.Roushan, Mohammad Reza HansanjaniRubinstein, EthanSipsas, Nikolaos V.Solera, JavierYoung, Edward J.Pappas, GeorgiosBrucel·losiMalalties infecciosesTerapèuticaBrucellosisCommunicable diseasesTherapeuticsBrucellosis is probably the commonest anthropozoonotic infection worldwide [1-3], but remains in various aspects an enigma in the 21st century [4]. Brucella melitensis remains the major cause of human disease worldwide, followed by B. abortus and B. suis, while rare but persisting cases of B. canis human infection and disease by novel Brucella pathogens of marine mammals have also emerged. The disease is re-emerging as a significant cause of travel-related disease [5] and represents an index of poor socioeconomic status (Figure 1). Its treatment is largely based even today on the principles applied half a century ago by pioneer researchers [6] and few modifications have been made in the following years, despite the emergence of new antibiotic classes and different therapeutic approaches [7].Public Library of Science (PLoS)2013201320072013info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion7 p.application/pdfapplication/pdfhttps://hdl.handle.net/2445/43769Articles publicats en revistes (Ciències Clíniques)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: 10.1371/journal.pmed.0040317PLoS Medicine, 2007, vol. 4, num. 12, p. 1872-1878http://dx.doi.org/10.1371/journal.pmed.0040317cc-by (c) Ariza Cardenal, Javier et al., 2007http://creativecommons.org/licenses/by/3.0/esinfo:eu-repo/semantics/openAccessoai:recercat.cat:2445/437692026-05-29T05:05:01Z
dc.title.none.fl_str_mv Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
title Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
spellingShingle Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
Ariza Cardenal, Javier
Brucel·losi
Malalties infeccioses
Terapèutica
Brucellosis
Communicable diseases
Therapeutics
title_short Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
title_full Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
title_fullStr Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
title_full_unstemmed Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
title_sort Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
dc.creator.none.fl_str_mv Ariza Cardenal, Javier
Bosilkowski, Mile
Cascio, Antonio
Colmenero, Juan D.
Corbel, Michael J.
Falagas, Matthew E.
Memish, Ziad A.
Roushan, Mohammad Reza Hansanjani
Rubinstein, Ethan
Sipsas, Nikolaos V.
Solera, Javier
Young, Edward J.
Pappas, Georgios
author Ariza Cardenal, Javier
author_facet Ariza Cardenal, Javier
Bosilkowski, Mile
Cascio, Antonio
Colmenero, Juan D.
Corbel, Michael J.
Falagas, Matthew E.
Memish, Ziad A.
Roushan, Mohammad Reza Hansanjani
Rubinstein, Ethan
Sipsas, Nikolaos V.
Solera, Javier
Young, Edward J.
Pappas, Georgios
author_role author
author2 Bosilkowski, Mile
Cascio, Antonio
Colmenero, Juan D.
Corbel, Michael J.
Falagas, Matthew E.
Memish, Ziad A.
Roushan, Mohammad Reza Hansanjani
Rubinstein, Ethan
Sipsas, Nikolaos V.
Solera, Javier
Young, Edward J.
Pappas, Georgios
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Brucel·losi
Malalties infeccioses
Terapèutica
Brucellosis
Communicable diseases
Therapeutics
topic Brucel·losi
Malalties infeccioses
Terapèutica
Brucellosis
Communicable diseases
Therapeutics
description Brucellosis is probably the commonest anthropozoonotic infection worldwide [1-3], but remains in various aspects an enigma in the 21st century [4]. Brucella melitensis remains the major cause of human disease worldwide, followed by B. abortus and B. suis, while rare but persisting cases of B. canis human infection and disease by novel Brucella pathogens of marine mammals have also emerged. The disease is re-emerging as a significant cause of travel-related disease [5] and represents an index of poor socioeconomic status (Figure 1). Its treatment is largely based even today on the principles applied half a century ago by pioneer researchers [6] and few modifications have been made in the following years, despite the emergence of new antibiotic classes and different therapeutic approaches [7].
publishDate 2007
dc.date.none.fl_str_mv 2007
2013
2013
2013
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/43769
url https://hdl.handle.net/2445/43769
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: 10.1371/journal.pmed.0040317
PLoS Medicine, 2007, vol. 4, num. 12, p. 1872-1878
http://dx.doi.org/10.1371/journal.pmed.0040317
dc.rights.none.fl_str_mv cc-by (c) Ariza Cardenal, Javier et al., 2007
http://creativecommons.org/licenses/by/3.0/es
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Ariza Cardenal, Javier et al., 2007
http://creativecommons.org/licenses/by/3.0/es
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 7 p.
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Public Library of Science (PLoS)
publisher.none.fl_str_mv Public Library of Science (PLoS)
dc.source.none.fl_str_mv Articles publicats en revistes (Ciències Clíniques)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869421685464104960
score 15,811543

Registos relacionados